Doctor in Medicine and Surgery from the Universidad del Rosario (Bogotá) and holds a PhD from the Institut Pasteur/Université Paris 7. Employed since 2017. He has performed academic work at the Pasteur Institute and the University of California, San Francisco on cancer immunotherapy. Andres was previously Chief Scientific Officer at Debiopharm, and has previously held senior roles at IDM and BioMérieux/ Pierre Fabre. Born 1956.

Shareholding: 3,009

Conditional Employee Options: Option program 2023/2025: 24,000, Option program 2024/2026: 15,000, Option program 2025/2027: 7,000

/sites/bioinvent/files/bioinvert/investors/corporate-governance/management-team/mcallister-andres.png Chief Medical Officer Management Team Off